Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea flag South Korea · Delayed Price · Currency is KRW
81,500
-10,000 (-10.93%)
At close: Mar 4, 2026
0.87%
Market Cap 1.07T
Revenue (ttm) 1.68T
Net Income (ttm) 59.24B
Shares Out 13.18M
EPS (ttm) 4,500.58
PE Ratio 18.11
Forward PE 16.09
Dividend 1,100.00 (1.20%)
Ex-Dividend Date n/a
Volume 72,762
Average Volume 50,898
Open 89,400
Previous Close 91,500
Day's Range 80,300 - 89,500
52-Week Range 70,900 - 106,800
Beta 0.37
RSI 33.50
Earnings Date Mar 18, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1941
Employees 2,253
Stock Exchange Korea Stock Exchange
Ticker Symbol 185750
Full Company Profile

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.

Financial Statements

News

There is no news available yet.